Unfortunately, these studies will not assess the progression of aortic stenosis or aortic events, and further clinical studies should be specifically performed to evaluate the pharmacological-induced Lp(a) reduction in this clinical setting. The gene discussed is LPA; the disease is aortic stenosis.